Renato Dulbecco - Working on cancer (36/61)
54 views · Published 1 November 2017 · 4:53 · Indexed 20 October 2026
Channel: Web of Stories - Life Stories of Remarkable People · 2017 · Science & Technology
To listen to more of Renato Dulbecco’s stories, go to the playlist: https://www.youtube.com/playlist?list=PLVV0r6CmEsFwzIooOixRbz6qqo-CwbTjK Italian biologist Renato Dulbecco (1914-2012) was a pioneer in the study of viruses. It was his plaque assay technique that facilitated most of the further major discoveries in virology. He was co-recipient of the Nobel Prize in Physiology or Medicine in 1975. [Listener: Paola De Paoli Marchetti; date recorded: 2005] TRANSCRIPT: So we returned there, and when we returned to 'La Jolla' and I returned to the Salk Institute, I started to think of the future, about what I would do because the work on viruses was essentially finished, there were other things that could be done, but I don't know, it didn't seem worth it to me to spend the rest of my life working on this. And I therefore thought that it would be interesting to start working on more complex systems. The system that caught my attention was cancer, still the field of cancer, because what I had worked on before was within the field of cancer, however I now wanted to concentrate on real cancer, breast cancer. And there were two reasons why I chose this: one because it is a very widespread cancer that affects many women, and the other because the wife of one of my dear friends at Caltech had developed breast cancer. So, I felt to a certain degree that it was my duty to try and work in this area as the cancer attacked directly rather than indirectly, as I had been studying previously. And so straightaway you can see the complexity. It's good to talk about breast cancer, but the breast, what is the breast, what cells are present there and how can one be distinguished from another, how do they develop, etc. and therefore I started to study this. I focused on rats, because they are a fairly good animal for this type of work. Studying both the formation, the development of the breast of the rat and cellular types that could be found in the rat, making cell cultures to see how they behaved, in fact, with a small number of collaborators, we made some progress in this field. Then, something that was very important and that deserved to be developed more than we developed it, is that I decided... in fact, we needed resources to identify the various cells that there were and naturally one of the means is simple, that of the microscope, but this is very rough. So, genes, speaking about genes it wasn't possible, because we didn't know anything about genes. Then the only thing that could be done was to go to the point after genes, which is proteins. And to study proteins, the means that were available then were monoclonal antibodies. Antibodies are molecules that connect specifically to a type of protein called monoclonal, because the clone is... the number of cells is derived from a single cell, so they were monoclonal, because all the cells of this complex that produced the antibody produced a type of antibody that usually, if the cells are taken together with the organism, the blood, the production of antibodies is huge in number, but each is produced in minimal quantities, so they are not used. Therefore, the technology to produce these monoclonal antibodies was developed in England. There was... I knew one of the people involved in this well, so we decided to adopt this monoclonal method. Thus, we constructed a number of monoclonal antibodies, which each recognised a cell type. This allowed us, therefore, to start building how these cell types change, as if... the evolution, the development of these cell types and this sufficiently clarified the conditions of development of the mammary gland. One thing that would be very interesting, that unfortunately we didn't pursue, is that we also made monoclonal antibodies against breast cancer and we identified – these always in rats, therefore, not in humans – and we identified monoclonal antibodies specific to cancer. In fact, today, there are specific antibodies for breast cancer, that are used a lot in therapy.
More from this channel
-
0:44
David Weatherall - Entering medical school
-
1:33
Katharine Whitehorn - Embodying the 'Sluts' article
-
6:55
KG Subramanyan - Mohandas Gandhi's views on art
-
2:22
Baruch Blumberg - The link between some cancers and viruses
-
5:03
Carl Djerassi - How Picasso sculpture unveiled problems in my marriage
-
6:39
Renato Dulbecco - Three Nobels, just one class
-
2:26
Marek Edelman - Different criteria for measuring the value of human life
-
2:45
Jules Engel - So who is responsible for a great animation?